Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosisParis, December 24, 2025.

Learn about the role of neuroinflammation in both neurodegenerative diseases like multiple sclerosis (MS) and the ageing ...

When the first spasm hit, it was sharp, sudden, and paralyzing. Tamika Luciano thought her life was ending. The entire left side of her body seized. Her face tightened, her limbs stiffened, and for ...

Sanofi SNY announced that the FDA has issued a complete response letter (CRL) to its new drug application (NDA), seeking ...

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis: Paris Friday, December 26, 2025, 13:00 Hrs [IST] The US Foo ...

Trump on Friday announced what the White House described as the largest set of developments to date under his administration’s push to bring prescription drug prices in the United States in line with ...

A Cedars-Sinai study has identified a previously unknown role for astrocyte cells in how the brain responds to damage and ...

Capital is flocking to a few high-growth AI plays and ignoring other opportunities because of the AI trend in the markets.

The federal government has been exaggerating marijuana's hazards and ignoring its potential benefits for more than half a ...

The French drugmaker is looking to dealmaking after some experimental drugs missed their goals in clinical studies or were ...

Access Health CT estimated that roughly 52,000 Connecticut residents — about a third of the 151,000 enrolled — could lose coverage by 2034 if enhanced financial aid ends and Medicaid is cut.